MTOR and prostate carcinoma: This can be explained in part by the very low number of prostate tissues for our Western blot analysis but could also reflect the contradictory role of p-mTOR/mTOR found in prostate cancer patients whose elevated levels positively correlated with a favorable prognosis [40,41].